Since its discovery, cadmium (Cd) has played an important role in industry and brought
certain conveniences to mankind, used for electroplating and making rechargeable …

Drug development is expensive, time-consuming, and has a high failure rate. In recent
years, artificial intelligence (AI) has emerged as a transformative tool in drug discovery …

The COVID-19 pandemic has emphasized the urgency for effective antiviral therapies
against SARS-CoV-2. Targeting the main protease (3CLpro) of the virus has emerged as a …

Acute myeloid leukemia is an aggressive cancer, which, in spite of increasingly better
understanding of its genetic background remains difficult to treat. Mutations in the FLT3 gene …

It is of great importance to overcome potential incompatibility problems between dyestuffs
and antibodies (mAbs) for extensive commercial application of a dyestuff-chemistry-based …

Drug resistance causes catastrophic cancer treatment failures. Mutations in target proteins
with altered drug binding indicate a main mechanism of cancer drug resistance (CDR) …

Relative to isotropic organic solvent medium, the structure and conformation of a reactant
molecule in an organized and confining medium are often different. In addition, because of …

Fascin is a major actin‐binding protein (ABP) in filopodia and is highly expressed in
metastatic tumors. To inhibit its function, a potent inhibitor called NP‐G2‐044 is currently in …

Gilteritinib is a highly selective and effective inhibitor of the FLT3/ITD mutated protein, and is
used successfully in treating acute myeloid leukaemia (AML). Unfortunately, tumour cells …

Molecular generative models have exhibited promising capabilities in designing molecules
from scratch with high binding affinities in a predetermined protein pocket, offering potential …